Editorials
-
- ICD in primary prevention: the ugly duckling of Spain
- Ignacio Fernández Lozano
- Rev Esp Cardiol. 2022;75:2-4
-
- Magnetic resonance-assessed lipoprotein profile. The time has come for its clinical use
- Lluís Masana, Daiana Ibarretxe
- Rev Esp Cardiol. 2022;75:5-8
-
- Acute heart failure. The quintessential cardiac emergency
- Carlos Peña-Gil, Violeta González-Salvado, Jaume Figueras-Bellot
- Rev Esp Cardiol. 2022;75:9-11
-
Original articles
Arrythmias and cardiac stimulation
-
- Cost-effectiveness of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death
- Aida Ribera, Emmanuel Giménez, Gerard Oristrell, Dimelza Osorio, Josep Ramón Marsal, Lidia García-Pérez, Mónica Ballesteros, Eduard Ródenas, Yassin Belahnech, Roxana Escalona, Núria Rivas, Ivo Roca-Luque, Ignacio Ferreira-González, Mireia Espallargues
- Rev Esp Cardiol. 2022;75:12-21
-
Epidemiology, risk factors and prevention
-
- Advanced lipoprotein profile in individuals with normal and impaired glucose metabolism
- Carlos Puig-Jové, Esmeralda Castelblanco, Mireia Falguera, Marta Hernández, Berta Soldevila, María Teresa Julián, Albert Teis, Josep Julve, María Barranco-Altirriba, Josep Franch-Nadal, Manel Puig-Domingo, Emilio Ortega, Núria Amigó, Núria Alonso, Didac Mauricio
- Rev Esp Cardiol. 2022;75:22-30
-
- Epidemiology and treatment of heart failure in Spain: the HF-PATHWAYS study
- Antoni Sicras-Mainar, Aram Sicras-Navarro, Beatriz Palacios, Luis Varela, Juan F. Delgado
- Rev Esp Cardiol. 2022;75:31-8
-
Cardiomyopathy and heart failure
-
- Impact of hospital and emergency department structural and organizational characteristics on outcomes of acute heart failure
- Òscar Miró, María Pilar López-Díez, Carlos Cardozo, Luis Arturo Moreno, Víctor Gil, Javier Jacob, Pablo Herrero, Pere Llorens, Rosa Escoda, Fernando Richard, Aitor Alquézar-Arbé, Josep Masip, Ana García-Álvarez, Francisco Javier Martín-Sánchez, on behalf of the ICA-SEMES group
- Rev Esp Cardiol. 2022;75:39-49
-
- Outcome of patients with acute heart failure secondary to acute myocardial infarction treated with noninvasive mechanical ventilation
- Luna Carrillo-Alemán, Antonia López-Martínez, Andrés Carrillo-Alcaraz, Miguel Guia, Ana Renedo-Villarroya, Nuria Alonso-Fernández, Víctor Martínez-Pérez, Juan Miguel Sánchez-Nieto, Antonio Esquinas-Rodríguez, Domingo Pascual-Figal
- Rev Esp Cardiol. 2022;75:50-9
-
- Results of heart retransplantation: subanalysis of the Spanish Heart Transplant Registry
- Nahikari Salterain-González, Gregorio Rábago Juan-Aracil, Manuel Gómez-Bueno, Luis Almenar-Bonet, María Generosa Crespo-Leiro, José María Arizón del Prado, María Dolores García-Cosío, Manuel Martínez-Sellés, Sonia Mirabet-Pérez, José Manuel Sobrino-Márquez, José González-Costello, Félix Pérez-Villa, Beatriz Díaz-Molina, Luis de la Fuente-Galán, Teresa Blasco-Peiró, Iris P. Garrido-Bravo, Luis García-Guereta Silva, Nuria Gil-Villanueva, Ferrán Gran, Francisco González-Vilchez
- Rev Esp Cardiol. 2022;75:60-6
-
Focus on: Survival analyses in cardiovascular research, a practical guide
-
- Survival analyses in cardiovascular research, part I: the essentials
- Xavier Rossello, Maribel González-Del-Hoyo
- Rev Esp Cardiol. 2022;75:67-76
-
- Survival analyses in cardiovascular research, part II: statistical methods in challenging situations
- Xavier Rossello, Maribel González-Del-Hoyo
- Rev Esp Cardiol. 2022;75:77-85
-
Image in cardiology
-
- Local fibrinolysis with distal occlusion: “marinade” technique
- Leire Unzué, Eulogio García, Rodrigo Teijeiro-Mestre
- Rev Esp Cardiol. 2022;75:86
-
- Hyperflow syndrome after venoarterial ECMO implantation
- Victoria Andrea Hortigüela Martín, Gonzalo Aldámiz-Echevarría del Castillo, Rafael Hernández-Estefanía
- Rev Esp Cardiol. 2022;75:87
-
Scientific letters
-
- Aging-related ILK levels are associated with calcified aortic valve and circulating miR 199-3p levels
- Sandra Sánchez-Esteban, Alberto Cook, Paula Reventún, Carlos Zaragoza, José Luis Zamorano, Marta Saura
- Rev Esp Cardiol. 2022;75:88-91
-
- Virtual lipid clinic after acute coronary syndrome
- Rafael Vázquez García, Juan Enrique Puche García, Diego Mialdea Salmerón, Daniel Bartolomé Mateos, William Delgado Nava
- Rev Esp Cardiol. 2022;75:91-2
-
- Longer-term results of the cardiology e-consult program in patients with heart failure
- Sergio Cinza Sanjurjo, Pilar Mazón Ramos, Diego Iglesias Álvarez, Daniel Rey Aldana, Manuel Portela Romero, José R. González-Juanatey
- Rev Esp Cardiol. 2022;75:93-5
-
- Aorta Code: a pilot study of a health care network for patients with acute aortic syndrome
- Carlos Ferrera, Isidre Vilacosta, Pablo Busca, Alfonso Martín Martínez, Francisco Javier Serrano, Luis Carlos Maroto Castellanos, on behalf of the Multidisciplinary Aorta Code CardioRed1 Group
- Rev Esp Cardiol. 2022;75:95-8
-
- Epicardial adipose tissue attenuation in admitted patients with COVID-19
- Teresa Sevilla, Álvaro Aparisi-Sanz, Cristhian Aristizábal-Duque, Itziar Gómez-Salvador, Carlos Baladrón, Alberto San Román
- Rev Esp Cardiol. 2022;75:98-100
-
- Cardiovascular events after COVID-19 hospitalization: long-term follow-up
- Martín Negreira-Caamaño, Jorge Martínez-Del Río, Daniel Águila-Gordo, Cristina Mateo-Gómez, Maeve Soto-Pérez, Jesús Piqueras-Flores
- Rev Esp Cardiol. 2022;75:100-2
-
Letters to the Editor
-
- Nonpermanent atrial fibrillation in the new European Society of Cardiology guidelines
- Eduardo Vázquez Ruiz de Castroviejo, Antonio Linde Estrella, Francisco Manuel García García, Juan Carlos Fernández Guerrero
- Rev Esp Cardiol. 2022;75:103-4
-
- Nonpermanent atrial fibrillation in the new European Society of Cardiology guidelines. Response
- David Calvo, Elena Arbelo
- Rev Esp Cardiol. 2022;75:104
-
- Relevance of myocardial injury biomarkers to the prognosis of COVID-19 patients
- Eric Alcaide, Laia Álvarez Bota, Rosario Salas
- Rev Esp Cardiol. 2022;75:105
-
- Relevance of myocardial injury biomarkers to the prognosis of COVID-19 patients. Response
- Alicia Calvo-Fernández, Jaume Marrugat, Beatriz Vaquerizo
- Rev Esp Cardiol. 2022;75:106
-
- “Echocardiographic response” to sacubitril-valsartan: does it decrease defibrillation implantation, as well as the incidence of malignant arrhythmias?
- Beatriz Jáuregui, Juan Acosta, Xavier Bosch, Antonio Berruezo
- Rev Esp Cardiol. 2022;75:107-8
-
- “Echocardiographic response” to sacubitril-valsartan: does it decrease defibrillation implantation, as well as the incidence of malignant arrhythmias? Response
- Laia Carla Belarte-Tornero, Diana Mojón, Núria Farré
- Rev Esp Cardiol. 2022;75:108
-